Objectives: This study compared three parasitological methods applied simultaneously in individuals with untreated chronic Chagas' disease in order to determine their individual and combined performances.
Introduction
Chagas' disease is the most prevalent human parasitosis in Latin America, where there are between 15 and 16 million infected persons and 75 -90 million exposed to infection. At present, Chagas' disease constitutes a global public health problem due to the flow of migration to developed countries from the Latin American countries where Chagas' disease is endemic. In Chile, the endemic -enzootic area is distributed in rural and peri-urban areas of the eight most northern administrative regions and the Metropolitan Region; there are about 150000 infected persons. There is a current consensus that Chagas' disease must be treated in all its stages; nevertheless, treatment efficacy is hampered by the lack of reliable criteria of cure for the chronic cases.
1,2 PCR has become the most promising tool for parasitological studies before therapy and in follow-up after chemotherapy, showing greater sensitivity than the traditional parasitological tests such as xenodiagnosis (XD) and blood culture.
2 PCR can detect 2.5 parasite genome equivalents/mL of blood in agarose gels or 0.25 parasite genome equivalents/mL of blood after Southern hybridization. Thus a 2 mL blood sample containing at least one intact parasite or 0.5 genomic equivalents should be positive in a PCR reaction targeted to the 330 bp minicircle fragment of Trypanosoma cruzi kinetoplastid (kDNA). 3 In this study, PCR of peripheral blood (PCR-B), XD and PCR of faecal samples of triatomines fed on chronic chagasic patients (PCR-XD) were applied in order to determine their individual and global performances in untreated infected individuals.
Methods
The patients were 100 chronic chagasics (89 women and 11 men) from different areas of the provinces of Choapa and Combarbalá , IV Region, Chile, with ages between 17 and 72 years (average 39 years). Committee of the Faculty of Medicine, University of Chile, and volunteered to participate in the study. T. cruzi infection was determined by indirect immunofluorescence (IIF) and ELISA in our laboratories. A sample of 2 mL of peripheral blood was mixed with 6 M guanidine-HCl/0.1 M EDTA buffer (pH 8.0) and incubated at 988C for 15 min to break the minicircles of T. cruzi kinetoplasts. DNA extraction was performed on 200 mL of guanidine-mixed samples, using the FavorPrep Blood Genomic DNA Extraction kit (Favorgen Biotech) according to the manufacturer's instructions and maintained at 2208C until use. In parallel, XD was applied using two cylindrical wooden boxes, each containing seven uninfected third instar Triatoma infestans nymphs. The insects were allowed to feed for 20-30 min on the arm of each volunteer. Microscopic examination of faecal samples was performed 30, 60 and 90 days after feeding triatomines. 4 For PCR-XD, the faecal samples of all the triatomines obtained after 30, 60 and 90 days were mixed with PBS 7.2, incubated at 988C for 15 min and centrifuged at 4000 rpm for 3 min. The supernatants were pooled for DNA extraction and maintained at 2208C until use. The PCR-B and PCR-XD were performed in triplicate with oligonucleotides 121 and 122, which anneal to the four constant regions present in minicircles of T. cruzi, 4 to obtain 320 bp amplicons. The PCRs were performed in a final volume of 20 mL containing 2.5 mM MgCl 2 , 0.2 mM of each dNTP, 0.5 mM of each primer (121 and 122) and 1 U of GoTaq DNA polymerase (Promega). The amplification programme was performed in a TC 412 thermal cycler (Techne), and included an initial denaturation at 988C for 1 min and 648C for 2 min; 33 cycles of 948C for 1 min, 648C for 1 min and 728C for 1 min, and a final incubation at 728C for 10 min. Each experiment included 5 mL of Bench Top 100 bp DNA ladder (Promega); a PCR control that contained water instead of DNA; DNA of non-chagasic patients and a positive control, the purified DNA T. cruzi Tulahuén strain. Amplification products were analysed by electrophoresis in a 2% agarose gel and visualized by staining with ethidium bromide (Figure 1 ). 5 Statistical analysis was performed by means of the Cochran Q test to compare whether the three methods had the same percentage of positives. The McNemar a posteriori test was used to identify which methods had different percentages of positives.
Results and discussion
Chronic chagasic patients treated with benznidazole and evaluated in extended follow-up demonstrated a reduced risk of progression of cardiac alteration in comparison with a non-treated group. 6 On the other hand, chronic chagasic patients treated with nifurtimox or benznidazole in an extended follow-up demonstrated that the drugs had a beneficial effect on the evolution of the disease in at least 37% of the cases. 7 From this perspective, one of the most important challenges in the evaluation of the chemotherapeutic efficacy in chronic Chagas' disease is the establishment of trustworthy cure criteria. 1, 2 In the chronic period of the illness the parasitaemia is low, sub-patent and fluctuating, therefore simultaneous application of different parasitological techniques can increase the possibility of demonstrating T. cruzi circulating in chronic chagasic patients, who will then receive specific treatment. Nowadays, XD is used only by laboratories that have a bug nursery. It can be useful in cases of borderline serological results and for evaluation of the treatment of Chagas' disease and HIV co-infection. 8 T. infestans, the natural vector of T. cruzi that we used for XD, is fundamental for recovery of the biological material for PCR-XD. Our study demonstrated that PCR-XD (67%) was more sensitive than XD (14%) (P¼ 0.0001) and increased the sensitivity of detection of T. cruzi by 53% (Table 1) . T. cruzi detection by PCR-B was 58%, with a total of 84% positives when the three techniques were applied simultaneously (P ¼ 0.00001). Castro et al. (2002) compared two tests in three serial blood samples of 60 untreated chronic chagasic patients, demonstrating 70% positives for blood culture and 86.7% positives for PCR in samples obtained over a period of 1 year. The greater percentage obtained with PCR may be explained by the higher sensitivity of the test and by its application in serial samples, which allow the detection of circulating T. cruzi that could not be detected in one sample. 9 The usefulness of serial samples to improve the sensibility of PCR was reinforced by Araujo et al. (2002) , who demonstrated in dogs infected with T. cruzi an increase in positives from 67% to 100% when a second sample was taken into account. 10 The results suggest that the parasitological condition of Chagas' disease may be determined by PCR-B in successive blood samples or simultaneous tests.
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